MARIETTA, Ga., Oct. 29, 2025 — Leads & Copy — MiMedx Group, Inc. (Nasdaq: MDXG) announced its third quarter 2025 financial results, reporting the highest quarterly net sales in company history for the second consecutive quarter.
Net sales for the third quarter reached $114 million, a 35% increase year-over-year. GAAP net income and diluted earnings per share were $17 million and $0.11, respectively. Adjusted EBITDA was $35 million, representing 31% of net sales.
The company has raised its 2025 net sales growth expectations to the mid-to-high teens and anticipates an adjusted EBITDA margin of at least the mid-20% range for the full year.
MIMEDX will host a conference call today, October 29, 2025, at 4:30 PM ET, to review the results.
Contact:Matt NotarianniInvestor Relations470.304.7291mnotarianni@mimedx.com
Source: MiMedx Group, Inc.Source: MiMedx Group, Inc.
